Michael Singer

Insider Reports History

Location
Gaithersburg, MD
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Michael Singer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Singer:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cartesian Therapeutics, Inc. Director Common Stock 96,219 $813,050 $8.45 02 Jan 2026 as custodian
Cartesian Therapeutics, Inc. Director Common Stock 56,133 $474,323 $8.45 02 Jan 2026 Direct
Cartesian Therapeutics, Inc. Director Common Stock 14,788 $124,958 $8.45 02 Jan 2026 by spouse
Cartesian Therapeutics, Inc. Director Common Stock 7,127 $60,223 $8.45 02 Jan 2026 by trust
Cartesian Therapeutics, Inc. Director Stock Option (Right to Buy) 7,800 $6,162 $0.7900 02 Jan 2026 Direct

Insider Reports Filed by Michael Singer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RNAC Cartesian Therapeutics, Inc. 02 Jan 2026 2 $0 4 Director 06 Jan 2026, 16:18
RNAC Cartesian Therapeutics, Inc. 18 Nov 2025 1 $0 4 Director 19 Nov 2025, 18:35
RNAC Cartesian Therapeutics, Inc. 02 Jan 2025 2 $0 4 Director 06 Jan 2025, 16:19
RNAC Cartesian Therapeutics, Inc. 26 Dec 2024 1 $0 4 Director 30 Dec 2024, 16:14
RNAC Cartesian Therapeutics, Inc. 19 Nov 2024 1 $0 4 Director 21 Nov 2024, 18:51
RNAC Cartesian Therapeutics, Inc. 08 Apr 2024 14 $0 4 Director 10 Apr 2024, 21:47
RNAC Cartesian Therapeutics, Inc. 22 Dec 2023 3 $0 4 Director, 10%+ Owner 04 Jan 2024, 17:12
RNAC Cartesian Therapeutics, Inc. 13 Nov 2023 14 $0 4 Director, 10%+ Owner 15 Nov 2023, 16:41
RNAC Cartesian Therapeutics, Inc. 13 Nov 2023 0 $0 3 Director, 10%+ Owner 15 Nov 2023, 16:38